Skip to Main Content

Author Details

Sungyong You
Cedars-Sinai Medical Center
2008
110
30
PMIDPaper TitleJournal TitlePublished Year
37604982Bioinformatics in urology - molecular characterization of pathophysiology and response to treatment.Nat Rev Urol2024
35908246HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.Hepatology2023
37562753Complement C1q essential for aeroallergen sensitization via CSF1R<sup>+</sup> conventional dendritic cells type 2.J Allergy Clin Immunol2023
37905039ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer.bioRxiv2023
37484909Autonomous action and cooperativity between the ONECUT2 transcription factor and its 3' untranslated region.Front Cell Dev Biol2023
37172577Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment.Cell Metab2023
37066364Aging gene signature of IL-7 receptor alpha low effector memory CD8<sup>+</sup> T cells is associated with neurocognitive functioning in Alzheimer's disease.Res Sq2023
36509363PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration.Cancer Lett2023
36711067Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs.Nano Today2023
36045587Antagonizing CD105 and androgen receptor to target stromal-epithelial interactions for clinical benefit.Mol Ther2023
34450249Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.Mol Ther2022
35543075Circulating tumor cells: A step toward precision medicine in hepatocellular carcinoma.J Gastroenterol Hepatol2022
35638091Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race.Eur Urol Open Sci2022
35519421Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology.IEEE Open J Eng Med Biol2022
35618577Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients.Urol Oncol2022
36636695Activation of ONECUT2 by RB1 loss in castration-resistant prostate cancer.Am J Clin Exp Urol2022
35902588Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes.Nat Commun2022
36161213Hepatocellular carcinoma surveillance: current practice and future directions.Hepatoma Res2022
35918812Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti-PD-L1 Immune Checkpoint Therapy.J Natl Cancer Inst2022
35973929Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma.Urol Oncol2022
35124841Early detection of primary liver cancer using plasma cell-free DNA fragmentomics: Do all the pieces come together?Hepatology2022
35115556Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.Nat Commun2022
34897998BoxCar and shotgun proteomic analyses reveal molecular networks regulated by UBR5 in prostate cancer.Proteomics2022
35078507KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.Breast Cancer Res2022
34818445NUAK family kinase 2 is a novel therapeutic target for prostate cancer.Mol Carcinog2022
34728526Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity.Clin Cancer Res2022
34664394Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.Liver Transpl2022
33037017Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.Clin Cancer Res2021
33649313TMPRSS2 activity may mediate sex differences in COVID-19 severity.Signal Transduct Target Ther2021
33531653A comparative study of PCS and PAM50 prostate cancer classification schemes.Prostate Cancer Prostatic Dis2021
34948334On the Road to Accurate Protein Biomarkers in Prostate Cancer Diagnosis and Prognosis: Current Status and Future Advances.Int J Mol Sci2021
34427305Stromal androgen and hedgehog signaling regulates stem cell niches in pubertal prostate development.Development2021
34400895Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology.Int J Med Sci2021
34541033Loss of CDCP1 triggers FAK activation in detached prostate cancer cells.Am J Clin Exp Urol2021
34541032Scaffold attachment factor B1 regulates androgen degradation pathways in prostate cancer.Am J Clin Exp Urol2021
34329585Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy.Cancer Cell2021
34212072Covalent Chemistry-Mediated Multimarker Purification of Circulating Tumor Cells Enables Noninvasive Detection of Molecular Signatures of Hepatocellular Carcinoma.Adv Mater Technol2021
34203086The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma.Cancers (Basel)2021
33362108Microscope calibration protocol for single-molecule microscopy.Opt Express2021
32252184Pioglitazone Alters the Proteomes of Normal Bladder Epithelial Cells but Shows No Tumorigenic Effects.Int Neurourol J2020
31844180Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.Prostate Cancer Prostatic Dis2020
3201981027-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells.Mol Cancer Res2020
33055242LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies.Sci Transl Med2020
32944167Comprehensive palmitoyl-proteomic analysis identifies distinct protein signatures for large and small cancer-derived extracellular vesicles.J Extracell Vesicles2020
33000006Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.Eur Urol Open Sci2020
32792852<i>S</i>-Palmitoylation as a Functional Regulator of Proteins Associated with Cisplatin Resistance in Bladder Cancer.Int J Biol Sci2020
32619811IL-7 receptor alpha defines heterogeneity and signature of human effector memory CD8<sup>+</sup> T cells in high dimensional analysis.Cell Immunol2020
32895384Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.Nat Commun2020
32380981Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.BMC Cancer2020
30957416Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism.Proteomics2019
  • 1 - 50 of 110

Recommended Authors

Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 7
Cumming School of Medicine, University of Calgary
Career Start Year 2016
Number of shared co-authors 1
The University of Texas Southwestern Medical Center
Career Start Year 2016
Number of shared co-authors 2
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 2013
Number of shared co-authors 1
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 3
University of British Columbia
Career Start Year 2008
Number of shared co-authors 15
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 1
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 5
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 17
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 18
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
University of California san francisco
Career Start Year 2005
Number of shared co-authors 16
University of British Columbia
Career Start Year 2004
Number of shared co-authors 14
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 4
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Present address: Dxige Research Inc.
Career Start Year 2003
Number of shared co-authors 3
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 12
University of British Columbia
Career Start Year 2002
Number of shared co-authors 26
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 13
Genentech Inc.
Career Start Year 2002
Number of shared co-authors 0
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 4
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 1
The Ohio State University
Career Start Year 1997
Number of shared co-authors 1
University of California
Career Start Year 1996
Number of shared co-authors 5
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 32
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 6
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 13
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 24

Collaborators

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 38
Roswell Park Comprehensive Cancer Center
Co-authored papers 23
Co-authored papers 20
Cedars-Sinai Medical Center
Co-authored papers 15
Cedars-Sinai Medical Center
Co-authored papers 14
Cedars-Sinai Medical Center
Co-authored papers 13
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 11
University of Utah
Co-authored papers 10
David Geffen School of Medicine , University of California los angeles
Co-authored papers 8
David Geffen School of Medicine University of California Los Angeles
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Yale School of Medicine
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Veracyte Inc.
Co-authored papers 5
David Geffen School of Medicine , University of California los angeles
Co-authored papers 4
Thomas Jefferson University Hospital
Co-authored papers 4
Cleveland Clinic
Co-authored papers 4
Yale School of Medicine, Yale University
Co-authored papers 4
Johns Hopkins University School of Medicine
Co-authored papers 3
Co-authored papers 3
Cedars-Sinai Medical Center
Co-authored papers 3
Samuel Oschin Cancer Center, Cedars Sinai Medical Center
Co-authored papers 3
Veracyte inc.
Co-authored papers 3
Cedars-Sinai Medical Center 8700 Beverly Blvd
Co-authored papers 3
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 2
Yale School of Medicine, Yale University
Co-authored papers 2
National Institute On Aging
Co-authored papers 2
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 2
Samuel Oschin Comprehensive Cancer Institute
Co-authored papers 2
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 2